Furthermore, transgenic models like APP/PS1 and TgAPP mice provide important information on familial AD and amyloid pathology but may not fully translate to the more common sporadic, late-onset AD due to their overexpression of mutant proteins and the early-onset nature. This evidence concerns the gene PSEN1 and Alzheimer disease.